Abstract: The invention relates to a coating formulation for preparing a hydrophilic coating, wherein the hydrophilic coating formulation comprises a supporting monomer and/or polymer comprising at least 2 reactive moieties capable of undergoing polymerization reactions, a polyelectrolyte, a Norrish Type I photoinitiator, and a Norrish Type II photoinitiator.

Abstract: The invention relates to a process for increasing the molecular weight of a polyamide via solid-state post-condensation by exposing the polyamide in the solid-state at elevated temperature to an inert gas atmosphere, that comprises a step (a) wherein the gas atmosphere to which the polyamide is exposed has a dew temperature Tdew-1, followed by a step (b) wherein the gas atmosphere to which the polyamide is exposed has a dew temperature Tdew-2, whereby Tdew-1 is higher than Tdew-2. The effect is that a high molecular weight polyamide can be obtained in a shorter production time.

Abstract: The present invention is directed to a diagnostic composition for use in the viscoelastic analysis of a test liquid, and to a container (1) comprising same. The composition comprises at least an activator of coagulation, and, optionally CaCl2 an optionally, one or more inhibitors and/or coagulation components, wherein the composition is present as an essentially dry mixture of all constituents and in an amount sufficient for performing one single viscoelastic analysis of a specified blood or plasma sample. The present invention is further directed to a method of performing a viscoelastic analysis on a test liquid, and to the use of the diagnostic composition in such a method.

Abstract: Process for preparing a moulding composition comprising melt-mixing of a thermoplastic polymer, a non-metallic inorganic filler and elementary iron having a weight average particle size of at most 450 ?m to form a composition wherein the thermoplastic polymer forms a continuous phase. The invention further relates to a composition obtainable with the inventive process, the use thereof for making moulded parts, as well as to moulded parts and the use thereof in applications wherein the moulded part is exposed to elevated temperature.

Abstract: The present invention generally relates to a method for reducing the production of methane emanating from the digestion of animal by using one or more essential oil compounds selected from the group consisting of limonene, eugenol, a silicylate, quinoline, vanilla, thymol and a cresol, which are administered to the animal feed.

Abstract: Medical device, prosthesis, or packaging assembly made up of polymer body comprising at least one polymer having the formula R(LE)x wherein R is a polymeric core having a number average molecular weight of from 5000 to 7,000,000 daltons, and having x endgroups, x is an integer?1, E is an endgroup which is covalently linked to polymeric core R by linkage L, L is a divalent oligomeric chain which has at least 5 repeat units and which can self-assembly with L chains on adjacent molecules of the polymer, and moieties L and/or E in the polymer(s) may be the same as or different from one another in composition and/or molecular weight. The polymer body includes plural polymer molecules located internally within the body, at least some of which internal polymer molecules have endgroups that form a surface of the body. The surface endgroups include at least one self-assembling moiety.

Abstract: The present invention relates to the use of sesquiterpenes and derivatives thereof as components of animal feed or feed additives for the improvement of animal performance as well as to the corresponding animal feed or feed additives containing them.

Abstract: The invention relates to a radiation curable composition including a polyester urethane (meth)acrylate oligomer prepared from ortho-carboxylic polyester polyols, where the composition, after cure, has a secant modulus greater than about 600 MPa and an elongation at break of at least about 10%. The invention also relates to coated optical fibers and optical fiber ribbon including at least one coating derived from this composition, and to a process of making these coated optical fibers.

Abstract: The invention relates to coated optical fibers comprising soft primary coatings and to such primary coatings for protecting glass optical fibers having a sufficient high resistance against cavitation. In particular, the primary coatings have a cavitation strength at which a tenth cavitation appears (?10cav) of at least about 1.0 MPa as measured at a deformation rate of 0.20% min?1 and of at least about 1.4 times their storage modulus at 23° C. The coating preferably shows strain hardening in a relative Mooney plot, preferably has a strain energy release rate Go of about 20 J/m2 or more, and preferably has a low volumetric thermal expansion coefficient. The invention furthermore provides a method and apparatus for measuring the cavitation strength of a primary coating.

Abstract: The present invention relates to a multilayer coating in which a plurality of photocurable resin cured films are layered on a substrate, wherein at least two adjacent layers comprise the same hindered phenol-type antioxidant. The multilayer coating can be applied onto a substrate, such as glass fibers, vinyl chloride sheets, polycarbonate sheets, glass plates, polyethylene films, wood, acrylic sheets, metal plates, and the like.

Abstract: Thermoplastic elastomer composition, comprising an thermoplastic polyolefin and an dynamically vulcanized elastomer comprising monomer units of ethylene, an ?-olefin and optionally one or more non-conjugated polyenes and oil, having an oil/elastomer ratio of at least 2/1, having a content of thermoplastic polyolefin of less than 10 wt. % relative to the total weight of the thermoplastic elastomer composition, granulate of the composition having the capability of flowing out of a cylinder, held in vertical position, within 120 seconds, after being kept in that cylinder under a pressure of 465 kg/m2, at a temperature of 50° C., for a period of 1 hour, that cylinder having an internal diameter of 95.3 millimeter (mm) and a length of 356 mm and being filled for a length of between 326 and 338 mm.

Abstract: A process for the preparation of a metal-organic compound, comprising at least one imine ligand, characterized in that an imine ligand according to formula (1) or the HA adduct thereof, wherein HA represents an acid, of which H represents its proton and A its conjugate base, is contacted with a metal-organic reagent of formula (2) in the presence of at least 1, respectively at least 2 equivalents of a base, with Y?N—R as formula (1), wherein Y is selected from a substituted carbon, or nitrogen atom and R represents a substituent, and with Mv(L1)k(L2)l(L3)m(L4)nx as formula (2), wherein: M represents a group 4 or group 5 metal ion, V represents the valency of the metal ion, being 3, 4 or 5, L1, L2, L3, and L4 represent a ligand or a group 17 halogen atom on M and may be equal or different, X represents a group 17 halogen atom, k, l, m, n=0, 1, 2, 3, 4 with k+l+m+n+l=V.

Abstract: Detection arrangement and method for detecting presence of a residue in a sample include determining color values of the sample, associated with the L*a*b color model. A value of a composite parameter Z is calculated as follows: A=wL+waa+wbb where wL, wa and wb are weighting factors having a value depending on the residue and the sample. A determination is made whether or not the sample comprises more or less than a predetermined amount of the residue in dependence on the value of the composition parameter Z. In a preferred embodiment, the arrangement is used to detect antibiotic residues, e.g. penicillin-G, in food products, elg. Milk, or body fluids, e.g. blood, urine.

Abstract: The invention relates to a process for making high-performance polyethylene multi-filament yarn comprising the steps of a) making a solution of ultra-high molar mass polyethylene in a solvent; b) spinning of the solution through a spinplate containing at least 5 spinholes into an air-gap to form fluid filaments, while applying a draw ratio DRfluid; c) cooling the fluid filaments to form solvent-containing gel filaments; d) removing at least partly the solvent from the filaments; and e) drawing the filaments in at least one step before, during and/or after said solvent removing, while applying a draw ratio DRsolid of at least 4, wherein in step b) each spinhole comprises a contraction zone of specific dimension and a downstream zone of diameter Dn and length Dn with Ln/Dn of from 0 to at most 25, to result in a draw ratio DRfluid=DRsp*DRag of at least 150, wherein DRsp is the draw ratio in the spinholes and DRag is the draw ratio in the air-gap, with DRsp being greater than 1 and DRag at least 1.

Abstract: The present invention relates to a process for the preparation of an enantiomerically enriched optionally substituted indoline-2-carboxylic acid or a salt thereof, wherein an enantiomerically enriched chiral ortho-X-substituted phenylalanine compound, wherein X is a leaving group, is subjected to cyclisation, preferably at a temperature of below about 140° C., upon formation of the enantiomerically enriched indoline-2-carboxylic acid compound.

Abstract: A junction field effect transistor includes a channel region, a gate region coupled to the channel region, a well tap region coupled to the gate region and the channel region, and a well region coupled to the well tap region and the channel region. A double gate operation is achieved by this structure as a voltage applied to the gate region is also applied to the well region through the well tap region in order to open the channel from both the gate region and the well region.

Abstract: The present invention relates to an asparaginase having the width of the pH activity profile which is at least 3.5. Furthermore the invention relates to newly identified asparaginase polypeptide according to any one of SEQ ID NO: 2 or SEQ ID NO: 4 and to variants thereof and to polynucleotide sequences that encode such novel asparaginase variants. Furthermore the invention relates to the use of these novel asparaginase variants in industrial processes.

Abstract: The present invention relates to a novel process for the preparation of an organopolysiloxane functionalized with a benzalmalonate by hydrosilylation, said process involving the use of a hydroxy carboxylic acid or a cyclic ester thereof.

Abstract: The present invention describes natamycin comprising needle shaped crystals.

Abstract: The present invention is directed to the use of (a composition comprising) hydroxytyrosol as anti-aging agent. The composition, to which the present invention is also directed, does essentially not comprise resveratrol and is administered orally to animals. The present invention is further directed to anti-aging methods. “Anti-aging” meaning in the context of the present invention: retarding the aging processes in said animals, improving age-related physiological deficits in said animals and/or promoting a healthy aging in said animals.